Obesity-associated improvements in metabolic profile through expansion of adipose tissue
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
Excess caloric intake can lead to insulin resistance. The underlying reasons are complex but likely related to ectopic lipid deposition in nonadipose tissue. We hypothesized that the inability to appropriately expand subcutaneous adipose tissue may be an underlying reason for insulin resistance and beta cell failure. Mice lacking leptin while overexpressing adiponectin showed normalized glucose and insulin levels and dramatically improved glucose as well as positively affected serum triglyceride levels. Therefore, modestly increasing the levels of circulating full-length adiponectin completely rescued the diabetic phenotype in ob/ob mice. They displayed increased expression of PPARgamma target genes and a reduction in macrophage infiltration in adipose tissue and systemic inflammation. As a result, the transgenic mice were morbidly obese, with significantly higher levels of adipose tissue than their ob/ob littermates, leading to an interesting dichotomy of increased fat mass associated with improvement in insulin sensitivity. Based on these data, we propose that adiponectin acts as a peripheral "starvation" signal promoting the storage of triglycerides preferentially in adipose tissue. As a consequence, reduced triglyceride levels in the liver and muscle convey improved systemic insulin sensitivity. These mice therefore represent what we believe is a novel model of morbid obesity associated with an improved metabolic profile.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Adiponectin, for example, has been shown to induce angiogenesis in hypoxic fat pads and tumors (75,91)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [91]
Experimental — accuracy not yet measuredIn the citing paper
“These results are comparable to findings in which increasing the capacity of adipose tissue (66) or the liver (67) to incorporate fatty acids into TGs does not cause insulin resistance and can actually prevent HFD-induced insulin resistance (66).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [66]
In the citing paper
“we have previously demonstrated that overexpression of adiponectin in an ob/ob background improves vascularization and expansion of the subcutaneous fat pad in particular (91)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Self-citationDamiola, F., Le Minh, N., Preitner, N., Kornmann, B., Fleury-Olela, F., & Schibler, U. (2000) · Genes & Development · doi:10.1101/gad.183500 · Cited by 2,394
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
Self-citationCCR2 modulates inflammatory and metabolic effects of high-fat feeding
Weisberg, S. P., Hunter, D., Huber, R., Lemieux, J., Slaymaker, S., Vaddi, K., Charo, I., Leibel, R. L., & Jr., A. W. F. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24335 · Cited by 1,497
Research works printed but not linked: 1
- Ailhaud, 2001, Ann. Endocrinol. (Paris)., 62, S43
Cited by
Items 201–300 of 996
Vitamin D And Nonalcoholic Fatty Liver Disease (Nafld): Is It More Than Just An Association?
Kwok, R. M., Torres, D. M., & Harrison, S. A. (2013) · Hepatology · doi:10.1002/hep.26390 · Cited by 169
“Indeed, data suggest that when pioglitazone is given to NASH patients, adiponectin levels increase 2-fold to 3-fold with an associated improvement in IR as well as improved steatosis, necroinflammation, and fibrosis.(45) The role of vitamin D in adipokine activity is an active area of research.”
BackgroundAssociation of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
Boutari, C., Perakakis, N., & Mantzoros, C. S. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.1.33 · Cited by 167
“and an improved metabolic profile [26].”
Tan, C. Y., & Vidal-Puig, A. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360935 · Cited by 169
Vila, I. K., Badin, P.-M., Marques, M.-A., Monbrun, L., Lefort, C., Mir, L., Louche, K., Bourlier, V., Roussel, B., Gui, P., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.062 · Cited by 165
“Indeed, facilitated AT expansion is associated in transgenic mouse models with a better metabolic state (Kim et al., 2007; Kusminski et al., 2012; Medina-Gomez et al., 2007; Virtue and Vidal-Puig, 2008).”
BackgroundPalmitic acid is an intracellular signaling molecule involved in disease development
Fatima, S., Hu, X., Gong, R.-H., Huang, C., Chen, M., Wong, H. L. X., Bian, Z., & Kwan, H. Y. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03092-7 · Cited by 163
Jourdan, T., Djaouti, L., Demizieux, L., Gresti, J., Vergès, B., & Degrace, P. (2010) · Diabetes · doi:10.2337/db09-1482 · Cited by 161
“Epididymal and inguinal fat were surgically removed as representatives of visceral and subcutaneous fat, respectively (22).”
Shao, M., Vishvanath, L., Busbuso, N. C., Hepler, C., Shan, B., Sharma, A. X., Chen, S., Yu, X., An, Y. A., Zhu, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03196-x · Cited by 161
Iron and the pathophysiology of diabetes
Harrison, A. V., Lorenzo, F. R., & McClain, D. A. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022522-102832 · Cited by 161
“At least some of this salutary phenotype is direcdy linked to adiponectin insofar as it is ameliorated in adiponectin knockout mice and is consistent with the phenotype of mice overexpressing adiponectin (93).”
BackgroundShabalala, S. C., Dludla, P. V., Mabasa, L., Kappo, A. P., Basson, A. K., Pheiffer, C., & Johnson, R. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110785 · Cited by 178
WISP2 regulates preadipocyte commitment and PPARγ activation by BMP4
Hammarstedt, A., Hedjazifar, S., Jenndahl, L., Gogg, S., Grünberg, J., Gustafson, B., Klimcakova, E., Stich, V., Langin, D., Laakso, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211255110 · Cited by 158
“Overexpressing adiponectin in the adipose tissue in mice leads to morbid obesity but with hypercellular, rather than hypertrophic, adipose tissue and with maintained insulin sensitivity and metabolism (12).”
BackgroundSIRT1 Deacetylase in SF1 Neurons Protects against Metabolic Imbalance
Ramadori, G., Fujikawa, T., Anderson, J., Berglund, E. D., Frazao, R., Michán, S., Vianna, C. R., Sinclair, D. A., Elias, C. F., & Coppari, R. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.014 · Cited by 158
“…from controls (Figures 6B, 6D and 6E); iii) there were no correlations between glycemia and body weight or fat mass in diabetic and obese Sf1-Cre; Sirt1loxP/loxP HC-fed mice (Figures 4B, 4C, and S3D), and iv) increased adiposity does not always lead to glucose/insulin imbalance (Kim et al., 2007b).”
BackgroundEnhanced metabolic flexibility associated with elevated adiponectin levels
Asterholm, I. W., & Scherer, P. E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090647 · Cited by 157
Self-citationInteractions between host genetics and gut microbiome in diabetes and metabolic syndrome
Ussar, S., Fujisaka, S., & Kahn, C. R. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.07.004 · Cited by 157
“These findings are further substantiated by studies in mice demonstrating that maintaining subcutaneous adipocyte function during weight gain results in a metabolically healthier obese phenotype [38,39].”
BackgroundSansbury, B. E., Cummins, T. D., Tang, Y., Hellmann, J., Holden, C. R., Harbeson, M. A., Chen, Y., Patel, R. P., Spite, M., Bhatnagar, A., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.266395 · Cited by 156
Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1/FGFR1 signaling pathway in mice
Wang, S., Cao, S., Arhatte, M., Li, D., Shi, Y. X., Kurz, S., Hu, J., Wang, L., Shao, J., Atzberger, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16026-w · Cited by 168
Peterson, S. J., Drummond, G., Kim, D. H., Li, M., Kruger, A. L., Ikehara, S., & Abraham, N. G. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800046-jlr200 · Cited by 161
“The involvement of adiponectin in insulin sensitivity is well documented (15, 40, 44), as well as a role for adiponectin in promoting the storage of triglycerides (13).”
BackgroundLipoexpediency: de novo lipogenesis as a metabolic signal transmitter
Lodhi, I. J., Wei, X., & Semenkovich, C. F. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.09.002 · Cited by 151
“Leptin-deficient mice with adiponectin overexpression are morbidly obese yet metabolically healthy [9].”
BackgroundLi, F. Y. L., Cheng, K. K. Y., Lam, K. S. L., Vanhoutte, P. M., & Xu, A. (2011) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02216.x · Cited by 151
“The transgenic over-expression of adiponectin in ob/ob obese mice results in a significantly decreased number of infiltrated macrophages in adipose tissue as well as reduced systemic inflammation compared with wild-type obese mice, despite a marked expansion of adipose tissue in the transgenic mice (Kim et al. 2007).”
BackgroundThe many secret lives of adipocytes: implications for diabetes
Scherer, P. E. (2019) · Diabetologia · doi:10.1007/s00125-018-4777-x · Cited by 151
“Nevertheless, our laboratory and others have successfully developed murine models that allow us to effectively study these different metabolic states; from congenital lipodystrophy [21], inducible lipodystrophy [22], to obese and ‘massively obese yet metabolically healthy’ phenotypes [19, 23].”
Self-citationScaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent
Artis, D. R., Lin, J. J., Zhang, C., Wang, W., Mehra, U., Perreault, M., Erbe, D., Krupka, H. I., England, B. P., Arnold, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811325106 · Cited by 148
Mechanisms by which adiponectin reverses high fat diet-induced insulin resistance in mice
Li, X., Zhang, D., Vatner, D. F., Goedeke, L., Hirabara, S. M., Zhang, Y., Perry, R. J., & Shulman, G. I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922169117 · Cited by 150
“Given that prior studies have demonstrated that increased plasma adiponectin concentrations lead to accretion of WAT and improved glycemia in mice (34, 35), we hypothesized that the insulin-sensitizing properties of adiponectin might be due to protection against ectopic lipid deposition in insulin-responsive tissues.”
BackgroundSelf-citationSmith, J. D., Borel, A.-L., Nazare, J.-A., Haffner, S. M., Balkau, B., Ross, R., Massien, C., Alméras, N., & Després, J.-P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2550 · Cited by 148
Meyer, L. K., Ciaraldi, T. P., Henry, R. R., Wittgrove, A. C., & Phillips, S. A. (2013) · Adipocyte · doi:10.4161/adip.24953 · Cited by 147
Histone Deacetylase 9 Is a Negative Regulator of Adipogenic Differentiation
Chatterjee, T. K., Idelman, G., Blanco, V., Blomkalns, A. L., Piegore, M. G., Weintraub, D. S., Kumar, S., Rajsheker, S., Manka, D., Rudich, S. M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262964 · Cited by 146
Self-citationNov, O., Shapiro, H., Ovadia, H., Tarnovscki, T., Dvir, I., Shemesh, E., Kovsan, J., Shelef, I., Carmi, Y., Voronov, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053626 · Cited by 147
“According to this view, adipose tissue is the metabolically safe site for excessive lipid storage, hence when storage capacity is exhausted, lipid overflows to non-adipose tissues causing ectopic fat accumulation and in turn, metabolic dysfunction [35].”
BackgroundYin-Yang Regulation of Adiponectin Signaling by APPL Isoforms in Muscle Cells
Wang, C., Xin, X., Xiang, R., Ramos, F. J., Liu, M., Lee, H. J., Chen, H., Mao, X., Kikani, C. K., Liu, F., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010355 · Cited by 147
Metabolic syndrome: its history, mechanisms, and limitations
Oda, E. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0309-6 · Cited by 182
Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo
Landskroner-Eiger, S., Qian, B., Muise, E. S., Nawrocki, A. R., Berger, J. P., Fine, E. J., Koba, W., Deng, Y., Pollard, J. W., & Scherer, P. E. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2649 · Cited by 145
“Despite the massive hyperplasia of the fat pads in these mice overexpressing APN, the fat pads remain minimally inflamed and fully insulin sensitive and do not display the classic hallmarks of expansion under suboptimal conditions, such as hypoxia and macrophage infiltration (29).”
BackgroundInfluentialSelf-citationKeembiyehetty, C., Love, D. C., Harwood, K. R., Gavrilova, O., Comly, M. E., & Hanover, J. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.617779 · Cited by 145
“Adiponectin is known to promote insulin sensitivity through increased lipolysis (77) and altered signaling to store triglyceride in adipocytes to reduce triglyceride levels in liver and muscle (78).”
BackgroundTLE3 Is a Dual-Function Transcriptional Coregulator of Adipogenesis
Villanueva, C. J., Waki, H., Godio, C., Nielsen, R., Chou, W.-L., Vargas, L., Wroblewski, K., Schmedt, C., Chao, L. C., Boyadjian, R., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.014 · Cited by 144
“A similar finding was reported in ob/ob animals expressing an adiponectin transgene (Kim et al., 2007).”
ResultRole of Fat Body Lipogenesis in Protection against the Effects of Caloric Overload in Drosophila
Musselman, L. P., Fink, J. L., Ramachandran, P. V., Patterson, B. W., Okunade, A. L., Maier, E., Brent, M. R., Turk, J., & Baranski, T. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.371047 · Cited by 144
“Increasing fat storage in adipose tissue protects mice fromT2D (59, 60), and animals that cannot store fat normally are insulin-resistant when fed normal diets (61, 62).”
BackgroundAdipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome
Wang, M.-Y., Grayburn, P., Chen, S., Ravazzola, M., Orci, L., & Unger, R. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801981105 · Cited by 144
“(10) that expansion of the fat mass of congenitally obese mice improves their metabolic profile lends further credence to the idea.”
BackgroundResistin: Insulin resistance to malignancy
Codoñer‐Franch, P., & Alonso‐Iglesias, E. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.07.043 · Cited by 163
“function and cellular composition have an important effect on the systemic metabolic phenotype [80].”
BackgroundMetabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease
Kang, S., Lee, Y.-H., & Lee, J. E. (2017) · Yonsei Medical Journal · doi:10.3349/ymj.2017.58.3.479 · Cited by 143
“Overexpression of adiponectin prevents high-fat diet-induced obesity in rodents, and genetically eliminating adiponectin in obese mice facilitates increased fat in the liver.(66) Adiponectin reduces hepatic lipogenesis and increases β-oxidation through adiponectin receptor 1 (adipoR1)-mediated activation of ade-”
BackgroundChutkow, W. A., Birkenfeld, A. L., Brown, J. D., Lee, H.-Y., Frederick, D. W., Yoshioka, J., Patwari, P., Kursawe, R., Cushman, S. W., Plutzky, J., et al. (2010) · Diabetes · doi:10.2337/db09-1212 · Cited by 142
“For example, lipodystrophies are often associated with severe insulin resistance (3–5), whereas subsets of obese humans and mouse models exist with normal metabolic indexes despite markedly increased adipose mass (6).”
Self-citationInnate immune activation in obesity
Lumeng, C. N. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.002 · Cited by 142
“…mice which demonstrate hyperphagia, obesity, and insulin resistance mediated the gut microbiome (Vijay-Kumar et al., 2010) Several studies have demonstrated that TLR4 knockout mice are protected from insulin resistance with HFD feeding (Davis et al., 2008; Kim et al., 2007a; Shi et al., 2006).”
BackgroundLee, J. Y., Zhao, L., & Hwang, D. H. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00259.x · Cited by 142
Restricted Adipogenesis in Hypertrophic Obesity
Gustafson, B., Hammarstedt, A., Hedjazifar, S., & Smith, U. (2013) · Diabetes · doi:10.2337/db13-0473 · Cited by 142
“Furthermore, the animal model generated by Scherer and colleagues (20), with overexpression of adiponectin in the subcutaneous adipose tissue, induced massively obese mice with perfectly normal insulin sensitivity and metabolism.”
BackgroundRole of adipose specific lipid droplet proteins in maintaining whole body energy homeostasis
Konige, M., Wang, H., & Sztalryd, C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.007 · Cited by 139
Distinct regulatory mechanisms governing embryonic versus adult adipocyte maturation
Wang, Q. A., Tao, C., Jiang, L., Shao, M., Ye, R., Zhu, Y., Gordillo, R., Ali, A., Lian, Y., Holland, W. L., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3217 · Cited by 139
Self-citationHypothalamic AgRP‐neurons control peripheral substrate utilization and nutrient partitioning
Joly‐Amado, A., Denis, R., Castel, J., Lacombe, A., Cansell, C., Rouch, C., Kassis, N., Dairou, J., Cani, P. D., Ventura‐Clapier, R., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.250 · Cited by 166
“In order to directly challenge the ability of obese AgRP-ablated mice to dispose of TG, we administered an oral charge of lipids (olive oil 15 m l/g BW) (as described by Kim et al , 2007).”
InfluentialGustafson, B., & Smith, U. (2012) · Diabetes · doi:10.2337/db11-1419 · Cited by 138
“Several genetically engineered animal models also support this concept; for instance, overexpression of adiponectin in the adipose tissue leads to massive, but hyperplastic, obesity and the animals are perfectly metabolically normal (33).”
BackgroundAdiponectin protects against development of metabolic disturbances in a PCOS mouse model
Benrick, A., Chanclón, B., Micallef, P., Wu, Y., Hadi, L., Shelton, J. M., Stener-Victorin, E., & Wernstedt Asterholm, I. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708854114 · Cited by 137
“Furthermore, overexpression of adiponectin is associated with improved whole-body insulin sensitivity and profound positive effects within adipose tissue, such as increased mitochondrial density in adipocytes, smaller adipocyte size, and transcriptional up-regulation of factors involved in lipid storage through effici…”
BackgroundScherer, P. E. (2016) · Diabetes · doi:10.2337/db16-0339 · Cited by 133
“We have done this in rodents on several occasions, either through a direct overexpression of adiponectin (33) or through the manipulation of other critical cellular pathways, including interventions at the level of mitochondria (34).”
Self-citationInflammatory Concepts of Obesity
Rocha, V. Z., & Folco, E. J. E. (2011) · International Journal of Inflammation · doi:10.4061/2011/529061 · Cited by 151
“In another study, ob/ob mice overexpressing adiponectin showed improved glucose tolerance and reduced triglyceride levels compared to their nontransgenic ob/ob littermates in spite of being morbidly obese [36].”
BackgroundGetting the message across: mechanisms of physiological cross talk by adipose tissue
Lee, D.-E., Kehlenbrink, S., Lee, H., Hawkins, M., & Yudkin, J. S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2009 · Cited by 137
“In mouse models, overexpression or infusion of adiponectin enhances insulin action and protects against endothelial damage (189); indeed, modestly increasing levels of circulating adiponectin in ob/ob mice actually improved insulin action despite inducing morbid obesity (125).”
BackgroundTao, C., Sifuentes, A., & Holland, W. L. (2014) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.11.003 · Cited by 134
Metabolic control through glucocorticoid hormones: An update
Rose, A. J., & Herzig, S. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.03.007 · Cited by 144
Larter, C. Z., Yeh, M. M., Williams, J., Bell-Anderson, K. S., & Farrell, G. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.026 · Cited by 145
“The primary function of adiponectin appears to be to promote lipid storage in adipocytes, thereby protecting non-adipose tissue from lipotoxic accumulation of lipids [30].”
BackgroundRole of macrophage tissue infiltration in obesity and insulin resistance
Bourlier, V., & Bouloumié, A. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.05.001 · Cited by 158
“[23] Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, et al.”
BackgroundDuggan, C., Onstad, L., Hardikar, S., Blount, P. L., Reid, B. J., & Vaughan, T. L. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.02.017 · Cited by 131
Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension
Mair, K. M., Gaw, R., & MacLean, M. R. (2020) · Pulmonary Circulation · doi:10.1177/2045894020952023 · Cited by 129
“Evidence from animal models and cultured adipocytes suggests that the preserved expansion capability of subcutaneous white adipose tissue mitigates extensive visceral and hepatic fat accumulation and gives some protection against metabolic disease.(135) Indeed, lower body subcutaneous white adipose tissue does not cor…”
BackgroundAbdominal Obesity and Cardiovascular Disease: Is Inflammation the Missing Link?
Després, J. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.06.004 · Cited by 167
“5).(85-87) Furthermore, as a hypertrophic fat depot not competent for hyperplasia cannot properly expand to store the extra dietary lipids, there is as a result a spillover of these triglyceride molecules leading to their accumulation at undesired sites (heart, liver, skeletal muscle, pancreas) through a process calle…”
BackgroundBlanchard, P.-G., Festuccia, W. T., Houde, V. P., St-Pierre, P., Brûlé, S., Turcotte, V., Côté, M., Bellmann, K., Marette, A., & Deshaies, Y. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m021485 · Cited by 129
Self-citationAPPL1 Potentiates Insulin Sensitivity by Facilitating the Binding of IRS1/2 to the Insulin Receptor
Ryu, J., Galan, A. K., Xin, X., Dong, F., Abdul-Ghani, M. A., Zhou, L., Wang, C., Li, C., Holmes, B. M., Sloane, L. B., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.006 · Cited by 127
“Consistent with this view, adiponectin has been shown to reduce the levels of triglycerol and diglycerol and increase insulin secretion in vivo (Holland et al., 2011; Kim et al., 2007; Yamauchi et al., 2001), which may lead to enhanced tyrosine phosphorylation of the IR.”
BackgroundVascular biology of metabolic syndrome
Vykoukal, D., & Davies, M. G. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.01.003 · Cited by 127
Clinical problems caused by obesity
Kyrou, I., Randeva, H., Barber, T., Tsigos, C., Kaltsas, G. A., & Weickert, M. O. (2022) · Warwick Research Archive Portal (University of Warwick) · doi:10.82444/warw.33841351 · Cited by 127
Angiogenesis Associated With Visceral and Subcutaneous Adipose Tissue in Severe Human Obesity
Ledoux, S., Queguiner, I., Msika, S., Calderari, S., Rufat, P., Gasc, J.-M., Corvol, P., & Larger, E. (2008) · Diabetes · doi:10.2337/db07-1812 · Cited by 126
“In patients with abdominal obesity, stimulation of SAT angiogenesis associated with insulin-resistance may promote SAT hyperplasia, thus enhancing the storage capability of adipose tissue (45).”
BackgroundBurgess, A., Li, M., Vanella, L., Kim, D. H., Rezzani, R., Rodella, L. F., Sodhi, K., Canestraro, M., Martasek, P., Peterson, S. J., et al. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.151423 · Cited by 133
Adipose tissue mass and location affect circulating adiponectin levels
Turer, A. T., Khera, A., Ayers, C. R., Turer, C. B., Grundy, S. M., Vega, G. L., & Scherer, P. E. (2011) · Diabetologia · doi:10.1007/s00125-011-2252-z · Cited by 125
“Furthermore, overproduction of adiponectin appears to mimic the effects seen with chronic peroxisome proliferator-activated receptor (PPAR)-γ agonist treatments and triggers improvements in lipid metabolism through expression of a number of genes involved with lipid metabolism and adipogenesis, including PPAR-γ2 (also…”
Self-citationCuthbertson, D. J., Steele, T., Wilding, J. P., Halford, J. C., Harrold, J. A., Hamer, M., & Karpe, F. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.4 · Cited by 125
Alcalá, M., Sánchez‐Vera, I., Sevillano, J., Herrero, L., Serra, D., Ramos, M. P., & Viana, M. (2015) · Obesity · doi:10.1002/oby.21135 · Cited by 122
“However, in the vitamin E-treated mice, we found a significant reduction in collagen deposition, which, together with an enlargement in the adipocyte size, may be responsible for their improved metabolic phenotype (22).”
BackgroundKim, D., Burgess, A., Li, M., Tsenovoy, P. L., Addabbo, F., McClung, J. A., Puri, N., & Abraham, N. G. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135285 · Cited by 130
“Excessive generation of reactive oxygen species (ROS) is the underlying mechanism of endothelial injury, resulting in an accelerated rate of apoptosis and endothelial cell sloughing (Kruger et al., 2005; Bahia et al., 2006; Kim et al., 2007a).”
BackgroundResultKawakami, T., Hanao, N., Nishiyama, K., Kadota, Y., Inoue, M., Sato, M., & Suzuki, S. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.10.004 · Cited by 133
Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome
Abraham, N. G., Junge, J. M., & Drummond, G. S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.09.003 · Cited by 131
“Adiponectin is secreted only by adipose tissue and is associated with decreased body weight [206–209], suggesting that the HO-1-mediated increase in bilirubin and the number of smaller healthy adipocytes capable of secreting adiponectin is related to the effect of adiponectin on body weight loss and attenuation of inf…”
Amato, A. A., Rajagopalan, S., Lin, J. Z., Carvalho, B. M., Figueira, A. C. M., Lu, J. Y.-L., Ayers, S. D., Mottin, M., Silveira, R. L., Souza, P. C. T., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.332106 · Cited by 126
“Some amount of adipogenesis may be advantageous; transgenic mice that overexpress the PPAR target gene adiponectin experience an expansion of fat mass, which is tied to dramatic improvements in insulin sensitivity (45).”
BackgroundObesity and Metabolic Syndrome: An Inflammatory Condition
Scarpellini, E., & Tack, J. (2012) · Digestive Diseases · doi:10.1159/000336664 · Cited by 122
Yaghootkar, H., Lamina, C., Scott, R. A., Dastani, Z., Hivert, M.-F., Warren, L. L., Stancáková, A., Buxbaum, S. G., Lyytikäinen, L.-P., Henneman, P., et al. (2013) · Diabetes · doi:10.2337/db13-0128 · Cited by 122
Adipocytes under assault: Environmental disruption of adipose physiology
Regnier, S. M., & Sargis, R. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.028 · Cited by 132
Fernø, J., Varela, L., Skrede, S., Vázquez, M. J., Nogueiras, R., Diéguez, C., Vidal-Puig, A., Steen, V. M., & López, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020571 · Cited by 122
Adipose triglyceride lipase deficiency causes tissue-specific changes in insulin signaling
Kienesberger, P. C., Lee, D., Pulinilkunnil, T., Brenner, D. S., Cai, L., Magnes, C., Koefeler, H. C., Streith, I. E., Rechberger, G. N., Haemmerle, G., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047787 · Cited by 120
The Arrestin Domain-Containing 3 Protein Regulates Body Mass and Energy Expenditure
Patwari, P., Emilsson, V., Schadt, E. E., Chutkow, W. A., Lee, S., Marsili, A., Zhang, Y., Dobrin, R., Cohen, D. E., Larsen, P. R., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.011 · Cited by 120
“…development of obesity from the development of insulin resistance: they are strongly protected against the development of diabetes despite increased adiposity (Chen et al., 2008; Chutkow et al., 2010), reminiscent of PPAR-gamma agonist therapy and adiponectinoverexpressing mice (Kim et al., 2007).”
BackgroundAdiponectin in Cardiovascular Inflammation and Obesity
Aprahamian, T. R., & Sam, F. (2011) · International Journal of Inflammation · doi:10.4061/2011/376909 · Cited by 133
“Interestingly, chronic adiponectin overexpression increased subcutaneous fat mass and protected against diet-induced insulin resistance [28].”
BackgroundRelation of depot-specific adipose inflammation to insulin resistance in human obesity
Bigornia, S. J., Farb, M. G., Mott, M. M., Hess, D. T., Carmine, B., Fiscale, A., Joseph, L., Apovian, C. M., & Gokce, N. (2012) · Nutrition & Diabetes · doi:10.1038/nutd.2012.3 · Cited by 120
Adiponectin Inhibits Lipolysis in Mouse Adipocytes
Qiao, L., Kinney, B., Schaack, J. B., & Shao, J. (2011) · Diabetes · doi:10.2337/db10-1017 · Cited by 133
“Furthermore, modestly increasing serum adiponectin completely rescued the diabetic phenotype in ob/ob mice with significant expansion of adipose tissue (4).”
BackgroundHypoadiponectinemia—Cause or Consequence of Human “Insulin Resistance”?
Cook, J. R., & Semple, R. K. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2286 · Cited by 135
“(30), also likely to be maladaptive in the wild.”
BackgroundMethodInfluentialDatta, R., Podolsky, M. J., & Atabai, K. (2018) · JCI Insight · doi:10.1172/jci.insight.122289 · Cited by 119
The Metabolic Syndrome as a Concept of Adipose Tissue Disease
Oda, E. (2008) · Hypertension Research · doi:10.1291/hypres.31.1283 · Cited by 131
A Role of the Bile Salt Receptor FXR in Atherosclerosis
Hageman, J., Herrema, H., Groen, A. K., & Kuipers, F. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.197897 · Cited by 119
Hammarstedt, A., Graham, T. E., & Kahn, B. B. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-42 · Cited by 119
“The changes associated with this transgene did not impair insulin sensitivity at all [8].”
BackgroundResultSignaling mechanisms underlying the insulin-sensitizing effects of adiponectin
Cheng, K. K. Y., Lam, K. S. L., Wang, B., & Xu, A. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.06.006 · Cited by 129
Wu, W., Shi, F., Liu, D., Ceddia, R. P., Gaffin, R., Wei, W., Fang, H., Lewandowski, E. D., & Collins, S. (2017) · Science Signaling · doi:10.1126/scisignal.aam6870 · Cited by 118
Deivanayagam, S., Mohammed, B. S., Vitola, B. E., Naguib, G. H., Keshen, T. H., Kirk, E. P., & Klein, S. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.2.257 · Cited by 116
“Multivariate regression analyses of both insulin-mediated glucose disposal and the HISI with IHTG content, IAF volume, and triglyceride concentration as independent variables found that Downloaded from https://academic.oup.com/ajcn/article-abstract/88/2/257/4650341 by guest on 29 July 2018 there was no longer any sign…”
BackgroundInfluentialMethionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice
Malloy, V. L., Perrone, C. E., Mattocks, D. A. L., Ables, G. P., Caliendo, N. S., Orentreich, D. S., & Orentreich∥, N. (2013) · Metabolism · doi:10.1016/j.metabol.2013.06.012 · Cited by 123
Muscle-Adipose Tissue Cross Talk
Stanford, K. I., & Goodyear, L. J. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029801 · Cited by 116
“The concentration of adiponectin in circulation is inversely correlated to fat mass and is linked to increased insulin sensitivity (Berg et al. 2002; Kim et al. 2007).”
Westcott, D. J., DelProposto, J. B., Geletka, L. M., Wang, T., Singer, K., Saltiel, A. R., & Lumeng, C. N. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20091333 · Cited by 115
“This agrees with recent observations that overexpression of adiponectin in leptin-deficient animals led to adipose tissue expansion without inflammation and maintained insulin sensitivity despite profound obesity (Kim et al., 2007).”
ResultObesity Paradox in Lung Cancer Prognosis: Evolving Biological Insights and Clinical Implications
Zhang, X., Liu, Y., Shao, H., & Zheng, X. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.07.022 · Cited by 122
Liu, H.-Y., Hong, T., Wen, G.-B., Han, J., Zuo, D., Liu, Z., & Cao, W. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00374.2009 · Cited by 115
Coactivator function of RIP140 for NFκB/RelA-dependent cytokine gene expression
Zschiedrich, I., Hardeland, U., Krones, A., Díaz, M. B., Vegiopoulos, A., Müggenburg, J., Sombroek, D., Hofmann, T. G., Zawatzky, R., Yu, X., et al. (2008) · Blood · doi:10.1182/blood-2007-11-121699 · Cited by 126
“Promoter luciferase constructs containing the murine TNF 5 -flanking region, 3xCRE-Luc, p B-Luc, p Bmut-Luc, and the expression plasmids HA-CBP, Gal4-CBP, pCMV-HA-p300, p50, RelA (p65), RelB, c-Rel, mRIP140, Gal4-DBD-RelA, GST-RelAwild-type, GST-RelA(1-305) (RHD), GST-RelA(441-551) (TA), GST-CBP fragments, and pBK-HA-…”
MethodKnockdown of ANT2 reduces adipocyte hypoxia and improves insulin resistance in obesity
Seo, J. B., Riopel, M., Cabrales, P., Huh, J. Y., Bandyopadhyay, G. K., Andreyev, A. Y., Murphy, A. N., Beeman, S. C., Smith, G. I., Klein, S., et al. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0003-x · Cited by 112
van Eijk, M., Aten, J., Bijl, N., Ottenhoff, R., van Roomen, C. P. A. A., Dubbelhuis, P. F., Seeman, I., Ghauharali-van der Vlugt, K., Overkleeft, H. S., Arbeeny, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004723 · Cited by 112
“These mice however were morbidly obese, with more adipose tissue than their Lep littermates [5].”
BackgroundZach‐Avec, D., Brolinson, A., Fisher, R. M., Carneheim, C., Csikasz, R. I., Bertrand‐Michel, J., Borén, J., Guillou, H., Rudling, M., & Jacobsson, A. (2010) · The FASEB Journal · doi:10.1096/fj.09-152298 · Cited by 112
“Consistent with these observations, Kim and coworkers (43) show that a modest overexpression of adiponectin in adipose tissue of ob/ob mice (Adtg/ob mice) can rescue insulin resistance by an increased expansion of adipose tissue.”
ResultLuo, N., Liu, J., Chung, B. H., Yang, Q., Klein, R. L., Garvey, W. T., & Fu, Y. (2010) · Diabetes · doi:10.2337/db09-1338 · Cited by 112
“Therefore, modestly increasing the levels of circulating adiponectin in these transgenic mice completely rescued the diabetic phenotype in ob/ob mice (29).”
BackgroundMacrophages and the Regulation of Adipose Tissue Remodeling
Martinez-Santibañez, G., & Nien-Kai Lumeng, C. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161113 · Cited by 111
Vitamin C in the Treatment and/or Prevention of Obesity
García‐Díaz, D. F., Lopez‐Legarrea, P., QUINTERO, P., & Martínez, J. A. (2014) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.60.367 · Cited by 125
The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines
Field, B. C., Gordillo, R., & Scherer, P. E. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.569250 · Cited by 117
“Exogenous adiponectin administration is able to reverse the diabetic phenotype of ob/ob mice (125).”
BackgroundSelf-citationOf mice and men: Pinpointing species differences in adipose tissue biology
Börgeson, E., Boucher, J., & Hagberg, C. E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1003118 · Cited by 141
“Transgenic mice that develop hypertrophic obesity, such as the ob/ob and db/db mice, typically develop metabolic dysfunctions, whereas severely obese mice with hyperplastic fat containing many small adipocytes instead are able to remain relatively healthy (Shepherd et al., 1993; Boucher et al., 2002; Kim et al., 2007;…”
BackgroundFestuccia, W. T., Oztezcan, S., Laplante, M., Berthiaume, M., Michel, C., Dohgu, S., Denis, R. G., Brito, M. N., Brito, N. A., Miller, D. S., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1553 · Cited by 111
Self-citationBrøns, C., & Grunnet, L. G. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0488 · Cited by 110
Mechanisms of obesity-induced metabolic and vascular dysfunctions
Caldwell, R. W. (2019) · Frontiers in bioscience · doi:10.2741/4758 · Cited by 122
“Overexpression of adiponectin in ob/ob mice results in healthy adipogenesis with expansion of the subcutaneous adipose tissue and insulin sensitivity similar to that of lean mice (142).”
Metadata
- Authors
- Kim, J.-Y., van de Wall, E., Laplante, M., Azzara, A., Trujillo, M. E., Hofmann, S. M., Schraw, T., Durand, J. L., Li, H., Li, G., Jelicks, L. A., Mehler, M. F., Hui, D. Y., Deshaies, Y., Shulman, G. I., Schwartz, G. J., & Scherer, P. E.
- Affiliations
- Université Laval (CA)
- Albert Einstein College of Medicine (US)
- University of Cincinnati (US)
- Howard Hughes Medical Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Scherer, Philipp E.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-09-04
- Volume
- 117
- Issue
- 9
- Pages
- 2621-2637
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1950456
- OpenAlex
- W2159346623
- Cited by
- 1,310
- References
- 61
- Citations by year
- 2026: 22 · 2025: 35 · 2024: 46 · 2023: 43 · 2022: 67 · 2021: 66 · 2020: 57 · 2019: 64 · 2018: 67 · 2017: 73 · 2016: 62 · 2015: 76 · 2014: 96 · 2013: 115 · 2012: 88
- FWCI
- 58.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- American Heart Association
- National Institutes of Health (DK 59630, DK026687)
- Albert Einstein College of Medicine, Yeshiva University
- National Cancer Institute (R01CA112023)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 59630, R01 DK 55758, R01DK040936, U24DK059635, R01DK055758, DK026687, R01DK066618, U24DK059630, R24DK071030, R21DK075887, R24-DK071030-01, P30DK026687)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- adiponectin, leptin deficiency, ob/ob mice, morbid obesity, insulin resistance, adipose tissue expansion, ectopic fat deposition, PPARγ target genes, macrophage infiltration, systemic inflammation, triglyceride storage, beta-cell failure, metabolic profile
- MeSH terms
- Adipose Tissue, Animals, Animal Feed, Diglycerides, Fats, Gene Expression Regulation, Immunohistochemistry, Insulin, Insulin Resistance, Islets of Langerhans, Lipoproteins, Liver, Macrophages, Mice, Transgenic, Obesity, Organ Size, Phenotype, Triglycerides, Leptin, PPAR gamma, Mice, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.